C-1‘-Branched acyclovir derivatives. Synthesis and antiviral evaluation

Nucleosides and Nucleotides

Volumn 8, Issue 8, 1989, Pages 1441-1451

  Seheiner, Peter ^a   Geer, Aloma ^a   Bucknor, Ann Marie ^a   Gadler, Hakan ^a,b   Price, R W ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ACICLOVIR DERIVATIVE; THYMIDINE KINASE;

ARTICLE; CYTOMEGALOVIRUS; DRUG SCREENING; DRUG SYNTHESIS; HERPES SIMPLEX; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; VARICELLA ZOSTER VIRUS;

CYTOMEGALOVIRUS; HERPES; HUMAN HERPESVIRUS 3;

EID: 0024955509     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328318908048852     Document Type: Article

References (18)

1. Schaeffer, H.J.; Beauchamp, L.; Miranda, P.; Elion, G.; Bauer, D. J.; Collins, P. Nature London 1978, 272, 583.
2. (a) Declercq, E.; Walker, R.T.; ‘Progress in Medicinal Chemistry’, Ellis, G.P.; West, G.B. eds., Elsevier, 1986, vol. 23, ch. 5. (b) Chu, C.K.; Cutter, S.J. J. Heterocyclic Chem. 1986, 22, 289. (c) Remy, R.J. Secrist, J.A. Nucleosides. Nuciotides 1985 4 411.
3. (a) Martin, J.C.; Dvorak, C.A.; Smee, D.F.; Matthews, T.R.;; Verheyden, J.P. H. J. Med. Chem. 1983, 26, 759. (b) Schaeffer, H.J. in Nucleosides. Nucleotides and Their Biologjcal appiications: Rideout, J.L.; Henry, D.W.; Beacham, L.M.; Eds.; Academic Press: New York, 1983; pp 1–17. (c) Ashton, N. J., Karkas, J.D.; Field, A.K.; Tolman, R.L. Biochem. Biophys. Res Comm. 1982, 108 1716, (d) Smith, K.O.; Galloway, K.S.; Kennell, W.L.; Ogilvie, K.K.; Radatus, B.K. Antimicrob. Agents Chemother. 1982, 22., 55.
4. Fyfe, J.A.; Keller, P.M.; Furman, P.A.; Miller, R.L.; Elion, G.B. J. Biol. Chem. 1978, 253, 8721.
5. Furman, P.A.; St. Clair, M.H.; Spector, T. J. Biol. Chem. 1984, 259, 9575. Derse, D.; Cheng, Y.-C.; Furman, P.A.; St. Clair, M.H.; Elion, G.B. J. Biol. Chem. 1981, 256 11447.
6. (a) Krenitsky, T.A.; Hall, W.W.; De Miranda, P.; Beauchamp, L.M.;; Schaeffer, H.J.; Whiteman, P.D. Proc. Natl. Acad Sci. USA 1984 81, 3209. (b) Good, S.S.; Krasny, H.C.; Elion, G.B.; de Miranda, P.J.jEllarmacol. Exp. Ther. 1983, 227, 644. (c) Spector, T.; Jones, T.E.; Beacham, L.M. Biochem. Pharmacol 1983, 32., 2505. (d) Martin, J.C.; Jeffrey, G.A.; McGee, D.P.C.; Tippie, M.A.; Smee, D.F.; Matthews, T.R.;Verheyden, J.P.H. J. Med. Chem. 1985, 28, 358.
7. Saxena, N.K.; Hagenow, B.M.; Genzlinger, G.; Turk, S.R.; Drach, J.C.; Townsend, L.B. J. Med. chem. 1988, 21, 1501.
8. Keller, P.M. Fyfe, J.A.; Beauchamp, L.; Lubbers, C.M.; Furman, P.A.; Schaeffer, H.J.; Elion, G.B. Biochem. Pharmacol. 1981, 30, 3071.
9. (a) Larsson, A.; Alenius, S.; Johansson, N.G.; Oberg, B. Antiviral Res. 1983, 2, 77. (b) Eklind, K.; Datema,R.; Ericson, A.C.; Hagberg, C.E.; Johansson, N.G.; Kovacs, S.; Larsson, A.; Lindberg, B.; Stening, G.; Oberg, B. Nucleosides Nucleotides 1985, 4, 303.
10. Johansson, N.G. Datema, R.; Eklind, K.; Kothammar, B. Hagberg, C.E.; Kovacs, S.; Larsson, A. Lindborg, B. Noren, J.O. Stening, G. Oberg, B. in ‘Innovative Approaches in Drug Research A.F. Harms ed., Elsevier, Amsterdam, 1986, p. 135.
11. Abele, G.; Karlstrom, A. Harmenberg, J. Shigeta, S.; Larsson, A.; Lindborg, B.A. Wahren, B. Antimicrob Agents Chemother. 1987, 31, 76.
12. (a) Ashton, W.T.Canning, L.F.;Reynolds, G.F. Tolman, R.L.; Karkas, J.D.; Liou, R.; Davies, M.E.; DeWitt C.M. Perry, H.C. Field, A.K. J. Med. Chem. 1985, 28, 926. (b) MacCoss, M.7 Chen, A.7 Tolman, R.L., Tetrahedron Lett., 1985, 26, 1815. (c) Lin, T.S.; Lin, M.C. Tetrahedron Lett. 1984, 2J5, 905.
13. Scheiner, P. Geer, A. Bucknor, A. M. Imbach, J.L. Schinazi, R.F. J. Med. Chem. 1989, 22, 73.
14. Shimizu, B. Chem. Pharm. Bull. 1970, 18, 1449.
15. Lira, E.P., Huffman, C.W. J. Org. Chem. 1966, 31, 2188.
16. Baker, B.R.Tanna, P.M. J. Org. Chem. 1965, 30, 2857.
17. Datema, R.; Ericson, A.C.; Field, H.J.; Larsson, A.; Stenberg, K. Antiviral Res. 1987, 7, 303.
18. Matulic-Adamic, J; Watanabe, K.A.; Price, R.W. chem. Scr., 1986, 26, 127.